AHMEDABAD: Sun Pharmaceuticals on Wednesday posted a 5% rise in its consolidated net profit which stood at Rs 2,375.5 crore for the second quarter of FY 2024. In the year-ago period, the company posted Rs 2,262.2 crore of profit, Sun Pharma said in a regulatory filing.The pharma major’s revenue stood at Rs 12,192 crore, up 11.3% from the year-ago period while its earnings before interest, taxes, depreciation, and amortization (EBITDA) came in at Rs 3,179 crore.Segment-wise, Sun Pharma's India formulation sales at Rs 3,842.5 crore, up 11.1% against...